Samantha Truex

Scoop: Saman­tha Truex de­parts At­las to head $200M Or­biMed-backed im­munol­o­gy start­up

Af­ter long­time biotech ex­ec­u­tive Sam Truex an­nounced last year she was shut­ting down her short-lived im­munol­o­gy start­up Quench Bio, she said she planned to …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.